Presence of 18q loss of heterozygosity (LOH) and disease-free and overall survival in stage II colon cancer: CALGB Protocol 9581 Bertagnolli, M. M. , Niedzwiecki, D. , Hall, M. , Jewell, S. D. ... - ASCO - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - GI - C9581
Dietary and lifestyle determinants of colon cancer recurrence and survival Fuchs, C. S. , Meyerhardt, J. A. , Ng, K. , Niedzwiecki, D. ... - NCI TSM - - 2008 Abstract - Secondary - Long-Term-Followup - GI - C89803
KRAS mutation, cancer recurrence and patient survival in stage III colon cancer: Findings from CALGB 89803 Fuchs, C. S. , Ogino, S. , Meyerhardt, J. A. , Irahara, N. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - GI - C89803
Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance) Fuchs, M. A. , Yuan, C. , Sato, K. , Niedzwiecki, D. , Ye, X. ... - - Ann. Oncol - 2017 Manuscript - Secondary - Primary - GI - CALGB-89803
A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803 Hasson, R. M. , Niedzwiecki, D. ... - AACR - Cancer Res. - 2012 Abstract - Secondary - Primary - GI - CALGB-89803
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 80303 Nixon, A. B. , Pang, H. , Starr, M. D. , Hollis, D. R. ... - - J. Clin. Oncol. - 2011 Abstract - Secondary - Primary - GI - CALGB-80303
KRAS mutation is not associated with recurrence or survival in 508 stage III colon cancers: Findings from multicenter adjuvant trial CALGB 89803 Ogino, S. , Meyerhardt, J. A. , Irahara, N. , Niedzwiecki, D. ... - AMP - Annual Meeting Association of Molecular Pathology - 2009 Abstract - Secondary - Primary - GI - C89803
Validation of a 12-gene colon cancer recurrence score (RS) in stage II colon cancer (CC) patients (pts) from CALGB 9581 Venook, A. P. , Niedzwiecki, D. , Lopatin, M. , Lee, M. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary - Primary - GI - C9581
A novel interaction of genotype, gender and adjuvant treatment in survival after resection of stage III colon cancer: Results of CALGB 89803 Warren, R. S. , Atreya, C. E. , Niedzwiecki, D. , Mayer, R. J. ... - - J. Clin. Oncol. - 2012 Abstract - Secondary - Primary - GI - C89803
